Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Resveratrol has been proposed as a potential therapeutic to improve metabolic health during pregnancy, yet little is known about the fetal effects of this maternal dietary supplement. We hypothesized that when administered to pregnant nonhuman primates (NHPs), resveratrol would increase uterine blood flow and mitigate the harmful consequences of maternal Western‐style diet (WSD) consumption. NHPs were fed a WSD (36% fat) supplemented with 0.37% resveratrol throughout pregnancy. Outcomes were compared with cohorts fed WSD alone and control chow (14% fat) to distinguish between WSD and resveratrol‐specific effects in these animals. In the early third trimester, uterine blood flow was measured by Doppler ultrasound before fetal delivery and tissue collection. Resveratrol resulted in 30% maternal weight loss and improved glucose tolerance, increased uterine artery volume blood flow, and decreased placental inflammation and liver triglyceride deposition. In addition, fetal pancreatic mass was enlarged by 42%, with a 12‐fold increase in proliferation by Ki67 immunohistochemistry. These results demonstrate that resveratrol use during pregnancy yields improvements in maternal and placental phenotype with beneficial effects in the fetal liver but an unexplained and concerning alteration in fetal pancreatic development, which strongly cautions against the use of resveratrol by pregnant women.—Roberts, V. H. J., Pound, L. D., Thorn, S. R., Gillingham, M. B., Thornburg, K. L., Friedman, J. E., Frias, A. E., Grove, K. L. Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates. FASEB J . 28, 2466–2477 (2014). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008
Ogden, C. L. (2010) · JAMA · doi:10.1001/jama.2009.2012 · Cited by 3,200 · cited 1×
“Indeed, according to recent studies, 17% of children and, of greatest concern, 10% of infants are above the 95th percentile for body weight (13), paralleling the recent”
BackgroundTimmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320 · cited 2×
“To date, weight loss has been demonstrated in obese rodent studies but has not been reported in short-term human clinical trials of resveratrol supplementation (6, 28).”
BackgroundMethodAMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol
Um, J.-H., Park, S.-J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., Kim, M. K., Viollet, B., & Chung, J. H. (2010) · Diabetes · doi:10.2337/db09-0482 · Cited by 647
High-Dose Resveratrol Supplementation in Obese Men
Poulsen, M. M., Vestergaard, P. F., Clasen, B. F., Radko, Y., Christensen, L. P., Stødkilde-Jørgensen, H., Møller, N., Jessen, N., Pedersen, S. B., & Jørgensen, J. O. L. (2013) · Diabetes · doi:10.2337/db12-0975 · Cited by 455 · cited 1×
“To date, weight loss has been demonstrated in obese rodent studies but has not been reported in short-term human clinical trials of resveratrol supplementation (6, 28).”
BackgroundKennedy, D. O., Wightman, E. L., Reay, J. L., Lietz, G., Okello, E. J., Wilde, A., & Haskell, C. F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28641 · Cited by 415 · cited 2×
“Since resveratrol improves inflammation and enhances blood flow in other organ systems (1, 8, 10), we sought to test the hypothesis that when administered to NHPs throughout pregnancy, resveratrol intervention would increase uterine blood flow, enhance placental function and mitigate the complications of a WSD in both…”
BackgroundPilot study of resveratrol in older adults with impaired glucose tolerance
Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., & Barzilai, N. (2012) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glr235 · Cited by 281
Frias, A. E., Morgan, T. K., Evans, A. E., Rasanen, J., Oh, K. Y., Thornburg, K. L., & Grove, K. L. (2011) · Endocrinology · doi:10.1210/en.2010-1332 · Cited by 268 · cited 4×
“Our group has previously reported that WSD exposure during pregnancy reduces cQuta (15).”
BackgroundInfluentialSelf-citationChronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults
Wong, R. H. X., Berry, N. M., Coates, A. M., Buckley, J. D., Bryan, J., Kunz, I., & Howe, P. R. C. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328362b9d6 · Cited by 162 · cited 1×
“In addition, resveratrol has been demonstrated as a vasodilator in human studies of cerebral artery blood flow (8), in brachial flow-mediated dilation (9), and in thyroid artery vascular reactivity studies from patients with hypertension and dyslipidemia (10).”
Background
Cited by
Sex and gender differences in developmental programming of metabolism
Dearden, L., Bouret, S. G., & Ozanne, S. E. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.04.007 · Cited by 345
The pharmacology of resveratrol in animals and humans
Park, E.-J., & Pezzuto, J. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.014 · Cited by 302
“The fetal pancreatic mass was abnormally enlarged by RSV treatment [342].”
BackgroundPlacental Function in Maternal Obesity
Kelly, A. C., Powell, T. L., & Jansson, T. (2020) · Clinical Science · doi:10.1042/cs20190266 · Cited by 227
Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology
Hirsch, A. J., Roberts, V. H. J., Grigsby, P. L., Haese, N., Schabel, M. C., Wang, X., Lo, J. O., Liu, Z., Kroenke, C. D., Smith, J. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02499-9 · Cited by 203
Self-citationKereliuk, S., Brawerman, G., & Dolinsky, V. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071451 · Cited by 90
“37% resveratrol for three months before breeding and during pregnancy induced increased maternal weight loss, improved glucose tolerance and uterine artery blood flow [103].”
BackgroundInfluential
Metadata
- Authors
- Roberts, V. H. J., Pound, L. D., Thorn, S. R., Gillingham, M. B., Thornburg, K. L., Friedman, J. E., Frias, A. E., & Grove, K. L.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2014-02-21
- Volume
- 28
- Issue
- 6
- Pages
- 2466-2477
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2141378847
- Cited by
- 116
- References
- 10
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates. https://app.cochat.ai/papers/10.1096/fj.13-245472
- The paper
- Roberts, V. H. J., Pound, L. D., Thorn, S. R., Gillingham, M. B., Thornburg, K. L., Friedman, J. E., Frias, A. E., & Grove, K. L. (2014). Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates. The FASEB Journal. https://doi.org/10.1096/fj.13-245472
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.